Fecal Pill Treats Gut Infection

In a preliminary study, patients with recurring Clostridium difficile infections found relief from diarrhea by ingesting frozen fecal matter from healthy volunteers.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Clostridium difficile sporesWIKIMEDIA, CJC2NDA handful of patients suffering from recurrent Clostridium difficile infections (CDI) experienced a cessation of the violent diarrhea that is a hallmark of the disease after ingesting frozen, encapsulated feces from healthy, unrelated volunteers. The results of the preliminary study to test the efficacy of the new twist on fecal microbiota transplantation (FMT) were published today (October 11) in the Journal of the American Medical Association (JAMA).

“If reproduced in future studies . . . these results may help make FMT accessible to a wider population of patients, in addition to potentially making the procedure safer,” the authors of the JAMA paper wrote. “The use of capsules obviates the need for invasive procedures for administration, further increasing the safety of FMT . . . and significantly reducing cost.”

CDIs are downright nasty to the human gut. They cause extreme diarrhea, abdominal pain, and, if left unchecked, death. The infections kill about 14,000 people in the U.S. alone every year. Such an insidious malady is apt to drive patients to drastic treatment measures. Direct fecal transplants, which transfer gut microbiota from healthy donors, have shown great promise in treating CDI’s, and last year ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery